Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

The aim of this study is to assess whether cell therapy with bone marrow-derived mesenchymal stem cells (BM-MSCs) can effectively treat cirrhosis patients with refractory ascites.

Notes

No additional information regarding therapeutic cells was provided by the sponsor.

This site does not provide medical advice and is for research use only

Welcome to
LifeMap Discovery

Watch the introductory video to learn more about our database of embryonic development for stem cell research and regenerative medicine

Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Product Information for

Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Therapeutic Cells

Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Diseases Related to

Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Research, preclinical and animal models for

Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Clinical Trials for

Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Related Cell Therapies

Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Literature related to

Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Welcome to LifeMap Discovery

Watch the introductory video to learn more about our database of embryonic development for stem cell research and regenerative medicine

Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Product Information for Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Therapeutic Cells Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Diseases Related to Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Research, preclinical and animal models for Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Clinical Trials for Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Related Cell Therapies Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Literature related to Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Welcome to
LifeMap Discovery

Product Information for

Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Therapeutic Cells

Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Diseases Related to

Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Research, preclinical and animal models for

Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Clinical Trials for

Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Related Cell Therapies

Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites

Literature related to

Bone marrow-derived mesenchymal stem cells for treatment of cirrhosis-related refractory ascites